Company Monitoring Page for JNJ

latest headlines for company on cafepharma

JP Morgan's Dimon hosted a private dinner for pharma executives, and a major topic was Amazon
CNBC
Thu, 01/10/19 - 09:50 am
Tags:
JNJ, Pfizer, Eli Lilly, Jamie Dimon, Amazon, JPMHC 2019
J&J still sees plenty of opportunity in crowded immunology markets—starting with psoriasis
Fierce Pharma
Wed, 01/9/19 - 12:56 pm
Tags:
JNJ, JPMHC 2019, immunology, psoriasis, Tremfya
Andexxa will go nationwide with FDA nod on Portola's commercial production of the bleeding antidote
Fierce Pharma
Wed, 01/2/19 - 11:38 am
Tags:
Portola Pharmaceuticals, AndexXa, Pfizer, Bristol-Myers Squibb, JNJ, Bayer, FDA, anticoagulant reversal
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
BioSpace
Fri, 12/21/18 - 12:10 pm
Tags:
clinical trials, Takeda, Zinfandel Pharmaceuticals, pioglitazone, Alzheimer's disease, Boehringer Ingelheim, BI 409306, Merck, verubecestat, Celgene, MS, ozanimod, Incyte, ID01, melanoma, vTv Therapeutics, azeliragon, Roche, Tecentriq, Exelixis, colorectal cancer, JNJ, atabacestat, Sareptat Therapeutics, DMD, Exondys 51, Alkermes, ALKS-5461, clinical depression
Judge refuses to overturn $4.7 billion talc powder verdict
Yahoo/AP
Thu, 12/20/18 - 11:47 pm
Tags:
JNJ, ovarian cancer
Johnson & Johnson tries to win back trust from investors with 5-billion-dollar share repurchase program
GoinPharma
Thu, 12/20/18 - 12:15 am
Tags:
JNJ, share repurchase
J&J hits back over asbestos in talc claims
Pharmaforum
Mon, 12/17/18 - 08:59 am
Tags:
JNJ, asbestos
J&J stock tumbles after Reuters reports it hid asbestos in talc
Fierce Pharma
Fri, 12/14/18 - 12:41 pm
Tags:
JNJ
Report: J&J willing to pay more than $400m to settle Pinnacle hip cases
Mass Device
Thu, 12/13/18 - 10:30 am
Tags:
JNJ, devices, Pinnacle Hip
J&J chief figures Amazon could shake up pharma's distribution, rebates and more
Fierce Pharma
Tue, 12/11/18 - 11:47 am
Tags:
Amazon, JNJ, Pharma CEOs, Alex Gorsky, distribution, drug rebates
Lessons From The Biggest Pharma Drug Launches Of All Time
Forbes
Tue, 12/11/18 - 10:26 am
Tags:
drug launches, Gilead Sciences, JNJ, Pfizer
ASH successes set to lift Imbruvica in CLL
Biopharma Dive
Thu, 12/6/18 - 07:01 pm
Tags:
AbbVie, Imbruvica, CLL, JNJ, ASH 2018
Actelion inks $360M deal to resolve DOJ kickbacks probe
Fierce Pharma
Thu, 12/6/18 - 06:54 pm
Tags:
JNJ, DOJ, PAH, Actelion, kickbacks
ASH: J&J's fast-growing Darzalex lines up for second front-line myeloma OK
Fierce Pharma
Tue, 12/4/18 - 11:33 am
Tags:
JNJ, Darzalex, Multiple Myeloma, ASH 2018
Should You Be Worried About the Return of Big Pharma Deals?
Motley Fool
Tue, 12/4/18 - 11:27 am
Tags:
GSK, Tesaro, M&A, Big Pharma, JNJ, Argenx
Vedanta pockets $12M from Johnson & Johnson on start of microbiome drug trial
Fierce Biotech
Wed, 11/28/18 - 10:04 am
Tags:
Vedanta Biosciences, JNJ, microbiome, IBD, VE202
Johnson & Johnson shares swoon as pharma giant loses yet another fight to protect Zytiga sales
Fierce Pharma
Tue, 11/27/18 - 12:12 pm
Tags:
JNJ, generics, Zytiga, Supreme Court, patents
J&J shares fall after court refuses to block Zytiga generics
Pharmaforum
Fri, 11/23/18 - 01:14 pm
Tags:
JNJ, generics, Zytiga, prostate cancer
A Small Group of Pharma Companies Is Making the Bulk of Medicines Necessary for Developing Countries
BioSpace
Fri, 11/23/18 - 01:08 pm
Tags:
GSK, JNJ, Novartis, Merck KGaA, Sanofi, Takeda, developing countries
Pfizer launches biosimilar version of Amgen's Epogen
Biopharma Dive
Wed, 11/14/18 - 11:45 pm
Tags:
Pfizer, biosimilars, Amgen, Epogen, JNJ, Procrit, anemia

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.